Glucagon-like peptide-1 receptor agonists decrease cancer incidences in type 2 diabetes: A cohort study using the database of Health Insurance Claims and Specific Health Checkups of Gifu and Mie Prefecture in Japan

Glucagon-like peptide-1 receptor agonists decrease cancer incidences in type 2 diabetes: A cohort study using the database of Health Insurance Claims and Specific Health Checkups of Gifu and Mie Prefecture in Japan - Glucagon-like peptide-1 receptor agonists decrease cancer incidences in type 2 diabetes: A cohort study using the database of Health Insurance Claims and Specific Health Checkups of Gifu and Mie Prefecture in Japan

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000051278

Enrollment

50000

Registered

2023-06-07

Start date

2019-11-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type2 diabetes

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Type2 Diabetes

Exclusion criteria

Exclusion criteria: the patients under 20 years old, treated without anti-diabetic drugs, not treated new drugs during observation period, with cancer, or undergoing dialysis treatment.

Design outcomes

Primary

Measure	Time frame
All cancer incidences during observation period	—

Secondary

Measure	Time frame
All cardiovascular events during observation period	—

Countries

Japan

Contacts

Public ContactRyoichi Ishibashi

Kimitsu Chuo Hospital Medicine, division of Diabetes, Endocrinology and Metabolism

ishibashi-cib@umin.net0438361071

Outcome results